Chun I. Yu

Wenzhou Medical University — China

Immunology and Microbiology · Life Sciences

17h-index1.4kcitations58works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(28), Cancer Immunotherapy and Biomarkers(13), Immune Cell Function and Interaction(12), CAR-T cell therapy research(12), T-cell and B-cell Immunology(8)

Publications58 total

Correlation analysis of Th1/Th2 cytokines and liver fibrosis indicators in chronic hepatitis B patients
Journal of Medical Biochemistry·2025Open Access
Intestinal inflammation mediates PFOA-induced sleep fragmentation and growth impairment in Drosophila
Ecotoxicology and Environmental Safety·2025· 2 citedOpen Access
miR-125b-5p regulates FFA-induced hepatic steatosis in L02 cells by targeting estrogen-related receptor alpha
Gene·2025· 1 citedOpen Access
2D MOFs nanosheets derived from 2D LDHs as a multifunctional sensitizer for sono-photodynamic therapy-mediated tumor treatment
Chemical Engineering Journal·2025· 17 cited
Protocol to construct humanized mice with adult CD34+ hematopoietic stem and progenitor cells
STAR Protocols·2024Open Access
Engraftment of adult hematopoietic stem and progenitor cells in a novel model of humanized mice
iScience·2024· 8 citedOpen Access
Long-term engraftment of adult hematopoietic progenitors in a novel model of humanized mice
2023Open Access
Molecular epidemiological characteristics of Brucella in Guizhou Province, China, from 2009 to 2021
Frontiers in Microbiology·2023· 10 citedOpen Access
Mouse models for immuno-oncology
Trends in cancer·2023· 29 cited
Supplementary Table 3 from Reprogramming Tumor-Infiltrating Dendritic Cells for CD103<sup>+</sup>CD8<sup>+</sup> Mucosal T-cell Differentiation and Breast Cancer Rejection
2023Open Access
Supplementary Table 1 from Reprogramming Tumor-Infiltrating Dendritic Cells for CD103<sup>+</sup>CD8<sup>+</sup> Mucosal T-cell Differentiation and Breast Cancer Rejection
2023Open Access
Supplementary Table 1 from Reprogramming Tumor-Infiltrating Dendritic Cells for CD103<sup>+</sup>CD8<sup>+</sup> Mucosal T-cell Differentiation and Breast Cancer Rejection
2023Open Access
Supplementary Table 2 from Reprogramming Tumor-Infiltrating Dendritic Cells for CD103<sup>+</sup>CD8<sup>+</sup> Mucosal T-cell Differentiation and Breast Cancer Rejection
2023Open Access
Supplementary Table 2 from Reprogramming Tumor-Infiltrating Dendritic Cells for CD103<sup>+</sup>CD8<sup>+</sup> Mucosal T-cell Differentiation and Breast Cancer Rejection
2023Open Access
Data from Reprogramming Tumor-Infiltrating Dendritic Cells for CD103<sup>+</sup>CD8<sup>+</sup> Mucosal T-cell Differentiation and Breast Cancer Rejection
2023Open Access
Data from Reprogramming Tumor-Infiltrating Dendritic Cells for CD103<sup>+</sup>CD8<sup>+</sup> Mucosal T-cell Differentiation and Breast Cancer Rejection
2023Open Access
Supplementary Table 3 from Reprogramming Tumor-Infiltrating Dendritic Cells for CD103<sup>+</sup>CD8<sup>+</sup> Mucosal T-cell Differentiation and Breast Cancer Rejection
2023Open Access
Abstract P5-01-05: Transcriptional signature of metastatic triple negative breast cancer in humanized mice
Cancer Research·2022
Mice with a humanized immune system are resilient to transplantation of human microbiota
2021Open Access
Abstract 1750: Human <i>KIT</i>+myeloid cells facilitate visceral organ colonization by melanoma
Cancer Research·2021
page 1 of 3Next →

Frequent Co-authors

Karolina Palucka(28), Jacques Banchereau(26), Florentina Marches(23), Te-Chia Wu(13), Virginia Pascual(12), Esperanza Anguiano(11), Romain Banchereau(10), SangKon Oh(10), Kangling Xu(9), Alexander Pedroza‐González(9), Joyce O’Shaughnessy(9), Stephen L. Nishimura(9), Chii‐Wann Lin(7), Christian Becker(6), Miriam Mérad(6), G. Jackson Snipes(6), Yuanyuan Wang(5), Adolfo Garcı́a-Sastre(5), Jan Martínek(5), Patrick Metang(4)